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Abstract
Background:  Repulsive guidance molecule c (RGMc or hemojuvelin), a
glycosylphosphatidylinositol-linked glycoprotein expressed in liver and striated muscle, plays a
central role in systemic iron balance. Inactivating mutations in the RGMc gene cause juvenile
hemochromatosis (JH), a rapidly progressing iron storage disorder with severe systemic
manifestations. RGMc undergoes complex biosynthetic steps leading to membrane-bound and
soluble forms of the protein, including both 50 and 40 kDa single-chain species.
Results: We now show that pro-protein convertases (PC) are responsible for conversion of 50
kDa RGMc to a 40 kDa protein with a truncated COOH-terminus. Unlike related molecules RGMa
and RGMb, RGMc encodes a conserved PC recognition and cleavage site, and JH-associated RGMc
frame-shift mutants undergo COOH-terminal cleavage only if this site is present. A cell-
impermeable peptide PC inhibitor blocks the appearance of 40 kDa RGMc in extra-cellular fluid, as
does an engineered mutation in the conserved PC recognition sequence, while the PC furin cleaves
50 kDa RGMc in vitro into a 40 kDa molecule with an intact NH2-terminus. Iron loading reduces
release of RGMc from the cell membrane, and diminishes accumulation of the 40 kDa species in
cell culture medium.
Conclusion:  Our results define a role for PCs in the maturation of RGMc that may have
implications for the physiological actions of this critical iron-regulatory protein.
Background
Iron is an essential element required for many cellular
processes, including energy metabolism, oxygen trans-
port, and respiration [1]. Iron homeostasis is tightly regu-
lated, and there are major health consequences linked to
both its deficiency and excess [1] Normal iron homeosta-
sis is disrupted in hemochromatosis, a heterogenous
hereditary disorder of iron overload. Juvenile hemochro-
matosis (JH) is a rapidly progressive form of this disease
with severe systemic consequences if untreated [3]. Many
patients with JH have mutations in the HJV gene, which
encodes hemojuvelin [4-7], and mice lacking hjv develop
an iron-overload phenotype [8,9]. Hemojuvelin is identi-
cal to RGMc, and with RGMa and RGMb, comprise the
repulsive guidance molecule (RGM) family [4,10,11].
RGMa and b are produced primarily in the central nervous
system [11,12], and play roles in neuronal survival and
patterning [11,12], while RGMc is synthesized in liver and
striated muscle [10,11,13,14]. All three RGM genes
encode glycosylphosphatidylinositol-anchored and solu-
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ble glycoproteins. For RGMc, these consist of single-chain
and heterodimeric membrane-linked molecules, and sol-
uble 50 and 40 kDa single-chain proteins that arise from
an incompletely defined biosynthetic and processing
pathway [14-17].
The mechanisms by which RGMc participates in systemic
iron balance are unknown. The liver-derived hormone,
hepcidin, is an essential regulator of iron homeostasis that
acts by controlling intestinal iron absorption and recovery
from macrophages [1]. Hepcidin binds to the membrane
iron transporter, ferroportin, leading to its degradation
[2]. In hemochromatosis, hepcidin levels are low, and die-
tary iron uptake is excessive [3]. Recent studies have sug-
gested that membrane-associated RGMc increases
hepcidin gene expression in the liver by collaboration
with signaling pathways activated by bone morphogenic
proteins (BMP) 2 and 4 [18,19], and thus acts to prevent
iron import. By contrast, soluble RGMc may inhibit hep-
cidin synthesis [15,20]. RGMc also may promote iron
uptake into cells [16], but biochemical mechanisms have
not been defined.
Here we demonstrate a role for pro-protein convertases
(PC) in the biogenesis of RGMc, and in their regulation by
iron. Through biochemical and cell-based approaches we
show that PCs cleave full-length 50 kDa RGMc at an evo-
lutionarily conserved recognition site into a 40 kDa solu-
ble species truncated at its COOH-terminus. Both 50 and
40 kDa RGMc are found in the blood of humans and
mice, and in extra-cellular fluid of cultured cells. The rela-
tive ratio and overall abundance of both RGMc species
appears to be altered by cellular iron levels, with iron
loading leading to a decline in soluble RGMc, but an
increase in the 50 kDa isoform and in the amount of sin-
gle chain RGMc retained on the cell membrane. Thus our
results define potential interactions between PCs and iron




All cells were incubated at 37°C in humidified air and 5%
CO2. The following established cell lines were used.
Murine C3H10T1/2 cells (ATCC #CCL-226, Manassas,
VA, USA) and C2 myoblasts [14] were grown on gelatin-
coated dishes in DMEM (Mediatech-Cellgro, Herndon,
VA, USA) plus 10% heat-inactivated fetal calf serum (FCS,
Hyclone, Logan, UT, USA). C3H10T1/2 cells were
infected at ~50% of confluent density with a recombinant
adenovirus encoding MyoD, as described [14], and mus-
cle differentiation-promoting medium (DMEM and 2%
horse serum (Hyclone)) was added 24 h later. C2 myob-
lasts were incubated at confluent cell density in muscle
differentiation-promoting medium, as described [14].
Cos-7 (ATCC #CRL-1651) and Hep3B cells (ATCC #HB-
8064) were grown in DMEM and 10% FCS. Ferric ammo-
nium choride or the iron chelator deferoxamine (Sigma,
St. Louis, MO, USA) was added to medium for 24 h.
Recombinant adenoviruses
Ad-MyoD, Ad-tTA (tetracycline transactivator protein),
Ad-HA-RGMc, and Ad-HA-RGMc∆GPI have been
described [14,21]. At 18 h after viral infection, new
medium was added (DMEM and 2% horse serum) con-
taining the cell-impermeable pro-protein convertase
inhibitor, decanoyl-Arg-Val-Lys-Arg-chloromethyl-ketone
[10  µM] (RVKR, Alexis Biochemicals, San Diego, CA,
USA) or DMSO. Cells and medium were harvested over
the next 24 h. Hep3B cells were infected at ~50% conflu-
ent density with Ad-HA-RGMc or Ad-HA-RGMc∆GPI, and
Ad-tTA, and treated similarly.
Expression of RGMc mutants
We previously cloned a mouse RGMc cDNA from skeletal
muscle cells [13]. The following codon changes were
introduced into the cDNA by site-directed mutagenesis
(Stratagene, San Diego, CA, USA): R318G, R321A, R324A.
Mouse RGMc truncation mutants were made by PCR by
replacing codons after R378, C354, S321 and Q305 with
a 6× His epitope tag and stop codon. These alterations cor-
respond respectively to human JH-associated frame-shift
mutations R385X, C361fsX366, S328fsX337 and Q312X
[4-7]. DNA sequencing was used to confirm all nucleotide
changes, and the regions with mutations were subcloned
into HA-RGMc in pcDNA3 [13]. Transient transfections
were performed using 2 µg of DNA/35 mm dish, and
RVKR or DMSO were added 18 h later. Cells and medium
were harvested after an additional 24 h.
Immunoblotting
Conditions for preparation of whole cell protein lysates
and culture medium, SDS-PAGE, and immunoblotting
have been described [14]. Primary antibodies included:
mouse RGMc (1:750 dilution) [14], HA (Covance, Den-
ver, PA, USA; 1:4000), α-tubulin (Sigma, 1:4000), His
(Abcam, Cambridge, MA, USA; 1:1000), and pan-cad-
herin (Cell Signaling, Danvers, MA, USA; 1:1000). Sec-
ondary antibodies included Alexa 680-conjugated anti-
mouse IgG (Molecular Probes, Eugene, OR, USA; 1:4000)
and IRD 800-conjugated anti-rabbit IgG (Rockland, Gil-
bertsville, PA, USA; 1:4000).
Purification of RGMc
An antibody affinity column was prepared by coupling
1.5 mg of antigen-purified rabbit anti-RGMc IgG to CNBr-
activated Sephadex 4B (Amersham-Pharmacia, Piscata-
way, NJ, USA). Serum was obtained from two healthy
humans (ages 25 and 35), and two male mice (age 10 and
12 weeks). Mouse or human serum (0.5 ml) or condi-BMC Biochemistry 2008, 9:9 http://www.biomedcentral.com/1471-2091/9/9
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tioned culture medium (1 ml) was diluted into 10 mM
TrisHCl, pH 7.4, 0.05% Tween-20, and protease inhibi-
tors (Roche, Indianapolis, IN, USA). Samples were pre-
cleared with protein-A agarose (Sigma) for 4 h at 4°C,
then incubated with affinity resin for 16 h at 4°C. Follow-
ing washes (10 column volumes of 10 mM TrisHCl, pH
7.4, 0.05% Tween-20), proteins were eluted with 0.5 ml of
100 mM glycine, pH 2.5, and neutralized with 1 M
TrisHCl, pH 8.0. A total of 50 µl was used for detection by
SDS-PAGE and immunoblotting [14].
Cell-surface biotin labeling
Monolayer cultures were incubated with EZ-link sulfo-
NHS-biotin (1 mg/ml, Pierce, Rockford, IL) for 30 min at
4°C, followed by incubation in medium ± RVKR, 'pull-
down' of protein extracts or culture medium with strepta-
vidin-agarose, and SDS-PAGE and immunoblotting [14].
Incubation of RGMc with cells or recombinant furin
Conditioned medium from cells expressing RGMc plus
RVKR was dialyzed to remove inhibitor. Aliquots (200 µl)
were added to Hep3B cells plus fresh RVKR or DMSO for
24 h at 37°C, followed by SDS-PAGE and immunoblot-
ting. Dialyzed medium (25 µl) was incubated with 10 U
recombinant human furin for 4 h at 30°C in 100 mM
Hepes, pH 7.4, 1 mM CaCl2, and 0.5% Triton-X100, fol-
lowed by SDS-PAGE and immunoblotting.
Results
A pro-protein convertase inhibitor prevents accumulation 
of soluble 40 kDa RGMc
RGMc is produced by hepatocytes and striated muscle
[8,13,15]. We have detected RGMc on muscle cell mem-
branes, and have found that proteins of ~50, 35, and 20
kDa are released into the extracellular fluid after incuba-
tion with bacterial PI-PLC [14], illustrating that RGMc is
attached to the membrane by a GPI linkage. The two
smaller protein bands comprise a disulfide-linked het-
erodimer, while the larger species is full-length single-
chain RGMc [14]. Similar results have been observed for
RGMc over-expressed in cell lines [14-16]. RGMc also
accumulates in medium conditioned by muscle cells as 50
and 40 kDa single-chain proteins [14], suggesting either
direct secretion or release from the plasma membrane.
Here we investigate mechanisms responsible for the
appearance of 40 kDa RGMc in extra-cellular fluid. Full-
length 50 kDa RGMc is a highly conserved protein, with
~76% homology among the 7 mammalian species shown
in Fig. 1A, and many stretches of amino acid identity,
including the arginine-rich segment found between resi-
dues 318 and 327 in mouse RGMc (Fig. 1A) that is not
conserved in RGMa or RGMb (Fig. 1B). This motif resem-
bles a recognition and cleavage site for pro-protein con-
vertases (PC). These enzymes, PC1, PC2, furin, PC4, PC5,
PACE4 and PC7 [22], cleave substrates at the COOH-ter-
minal basic residue in the sequence (K/R)-(X)n -(K/R),
where n = 0, 2, 4, or 6 amino acids and X is any residue
except Cys or Pro [22]. To determine if full-length RGMc
is a substrate for PCs, we first purified the soluble protein
by antibody affinity chromatography from culture
medium from differentiating muscle cells, and from
mouse and human blood. Both 50 and 40 kDa RGMc spe-
cies were detected from all three sources (Fig. 1C and 1D).
Surprisingly, serum concentrations differed substantially
between two healthy humans, and between two healthy
male mice of the same age and on the same diet, where in
one mostly the 50 kDa form of RGMc was detected (Fig.
1D, lane c vs. d). Further study will be required to assess
the mechanisms responsible for this variation. When
muscle cells, which produce RGMc [14], were incubated
with the peptide PC inhibitor, RVKR, the 50 kDa species
became the only RGMc protein in the medium (Fig. 1E),
implicating PC activity in processing of endogenous
RGMc. Similar results were seen in undifferentiated
mouse C2 myoblasts and in human Hep3B cells express-
ing HA-RGMc (Fig. 1F), although it should be noted that
the same dose of RVKR was less effective in Hep3B cells in
preventing accumulation of 40 kDa RGMc, implying that
there is more PC activity in this cell line.
Mapping the location of PC cleavage by analysis of JH-
associated RGMc frame-shift mutations
Several frame-shift mutations in human RGMc are associ-
ated with JH [4-7]. We mimicked four of these mutants in
NH2-terminal HA-tagged mouse RGMc, and added a 6×
His tag to each COOH-terminus (Fig. 2A). The mutant
proteins when expressed in Cos-7 cells accumulated in
culture medium, but not on the cell membrane, as they
lacked a GPI attachment sequence (Fig. 2B, and data not
shown). A doublet was seen in the medium of cells pro-
ducing the R378X and C354X mutants, but only a single
immunoreactive band with S321X and Q305X. As all pro-
tein species were detected with an antibody to the NH2-
terminal HA tag, this result suggests that the smaller
mutant proteins (and 40 kDa RGMc derived from RGM-
c∆GPI) may lack COOH-terminal residues (Fig. 2B). After
incubation of cells with RVKR, the larger member of the
protein doublet for R378X and C354X increased in abun-
dance in the medium, and was recognized by an antibody
to the COOH-terminal His tag, while the smaller of the
doublet bands was not (Fig. 2C). Similar results were seen
for RGMc∆GPI (Fig. 2C). In contrast, detection of S321X
and Q305X with the His antibody was constant and was
unaffected by RVKR. Taken together with observations in
Fig. 1, the results with truncation mutants demonstrate
that PC activity potentially removes a COOH-terminal
segment of RGMc, and indicate that the cleavage site is
located between amino acids 321 and 354 of the mouseBMC Biochemistry 2008, 9:9 http://www.biomedcentral.com/1471-2091/9/9
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A pro-protein convertase inhibitor prevents accumulation of soluble 40 kDa RGMc Figure 1
A pro-protein convertase inhibitor prevents accumulation of soluble 40 kDa RGMc. A. Map of mouse RGMc with 
RGD motif, von Willebrandt factor (vWF) type D domain, GPI anchor, and intra-molecular cleavage site (arrow) indicated. The 
conserved PC site (underlined, arginines bolded) is aligned below the map for 7 mammalian species. B. Absence of putative 
PC sites in RGMa or b. Alignment of human RGMa, b, and c; vertical lines or asterisks denote identical residues between paral-
ogous proteins. C. Immunoblot of affinity-purified RGMc from mouse serum and muscle cell conditioned medium, with 50 and 
40 kDa isoforms indicated. D. Immunoblot of affinity-purified RGMc from blood from two humans (a, b) and two mice (c, d), 
with 50 and 40 kDa isoforms indicated. Soluble HA-RGMc is included as a reference. E. Immunoblot of RGMc from muscle cell 
conditioned medium (50 µl) incubated without or with the small molecule PC inhibitor, RVKR. F. Immunoblot of RGMc from 
conditioned medium (25 µl) of C2 myoblasts or Hep3B cells infected with Ad-HA-RGMc and incubated ± RVKR. For C – F, 
black arrows indicate 50 kDa RGMc and white arrows 40 kDa.BMC Biochemistry 2008, 9:9 http://www.biomedcentral.com/1471-2091/9/9
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protein, in agreement with identification of a conserved
PC motif between residues 318 and 327 (Fig. 1A).
Altered processing of newly synthesized RGMc in the 
presence of PC inhibitor
To study effects of PC inhibition on RGMc biosynthesis
and maturation, we infected Hep3B cells with Ad-tTA and
Ad-HA-RGMc. Ad-tTA encodes a tetracycline-repressible
transcriptional activator that stimulates the promoter reg-
ulating the gene for HA-RGMc. Under these conditions,
full-length and heterodimeric RGMc were found on the
cell membrane beginning at 8 h after viral infection and
increased in abundance at 24 h. More membrane-associ-
ated RGMc was detected in RVKR-treated cells than in con-
trols, although there was no change in the pattern of
immunoreactive proteins. In culture medium 40 kDa
RGMc accumulated starting at 8 h, and the 50 kDa species
was only seen after incubation of cells with RVKR (Fig.
3A).
We used cell surface-labeling experiments to study the
impact of PC inhibition on acute release of membrane-
linked RGMc into the medium. In Hep3B cells expressing
HA-RGMc, membrane proteins were labeled for 30 min
with cell-impermeable biotin cross-linker followed by
addition of RVKR or vehicle. Release of RGMc from the
cell surface was monitored by immunoblotting after
streptavidin pull-down of culture medium. Biotinylated
40 and 50 kDa RGMc were detected in medium at 2 and
4 h after labeling, and more 50 kDa RGMc was seen with
RVKR, although the total amount of RGMc declined by
~35% (Fig. 3B). These results show that both 50 and 40
kDa soluble RGMc species derive from cell-associated 50
kDa RGMc, and demonstrate that inhibition of PC activity
diminishes but does not prevent release of membrane-
linked RGMc into extracellular fluid.
Furin cleaves 50 kDa RGMc to produce a 40 kDa species
We destroyed putative PC recognition/cleavage sites in
mouse RGMc by site-directed mutagenesis (glycine for
arginine 318, alanines for arginines 321 and 324). When
this mutant was expressed in Cos-7 cells, only 50 kDa
RGMc was detected in conditioned medium, while wild
type RGMc was processed to the 40 kDa species in the
absence of RVKR, but 50 kDa RGMc was seen when the
inhibitor was added (Fig. 4A).
PC activity may be found in intracellular compartments,
at the membrane, and in the extra-cellular milieu [22]. To
determine where cleavage of 50 kDa RGMc may occur,
conditioned medium from Cos-7 cells expressing HA-
RGMc was collected in the presence of RVKR, and after
dialysis to remove the inhibitor, added to Hep3B cells.
Following incubation for 24 h, significant conversion to
40 kDa RGMc was observed, but was not seen when RVKR
Juvenile hemochromatosis-linked RGMc COOH-terminal  truncation mutants are cleaved into smaller isoforms Figure 2
Juvenile hemochromatosis-linked RGMc COOH-ter-
minal truncation mutants are cleaved into smaller 
isoforms. A. Map of mouse RGMc showing locations of sig-
nal peptide (s.p.), RGD sequence, von Willebrandt type D 
domain, GPI-anchor motif, and putative PC site (R-X-X-R). 
RGMc∆GPI-His and RGMc frame-shift truncation mutants 
are pictured below. Each contains a COOH-terminal His tag. 
B. Detection of RGMc truncation mutants by immunoblot-
ting of protein lysates and conditioned medium from tran-
siently transfected Cos-7 cells using RGMc (upper panel) or 
HA antibodies (lower). C. Detection of RGMc truncation 
mutants by immunoblotting of conditioned medium after 
incubation ± RVKR using RGMc (upper panel) or His anti-
bodies (lower). For B and C, black arrows indicate 50 kDa 
single-chain RGMc and white arrows 40 kDa, and gray 
arrows mark NH2- and COOH-terminal fragments resulting 
from intra-molecular cleavage.BMC Biochemistry 2008, 9:9 http://www.biomedcentral.com/1471-2091/9/9
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was added (Fig. 4B), indicating that these cells produce
PCs that act extra-cellularly.
The R-N-R-R sequence in RGMc (Fig. 1A) represents an
optimal furin site [23]. In agreement with this idea, incu-
bation of 50 kDa RGMc with recombinant furin in vitro
led to its efficient cleavage into a 40 kDa species with an
intact NH2-terminus, as shown by detection with both
anti-HA and anti-RGMc antibodies (Fig. 4C). Thus by sev-
eral criteria, 50 kDa RGMc is a PC substrate.
Effects of iron on processing of RGMc and its release from 
the cell membrane
Recent work has shown that delivery of iron to cultured
cells resulted in a decline in abundance of extra-cellular
RGMc 24 h later [15,24]. To address effects of iron on
membrane-bound RGMc, adenoviral-infected Hep3B
cells were incubated with ferric ammonium citrate, briefly
labeled with cell-impermeable biotin cross-linker, and
examined for accumulation of RGMc on the cell mem-
brane and in the medium. As seen in Fig. 5A, iron loading
led to a dose-dependent increase in cell surface-associated
50 kDa RGMc, and to a decline in abundance of the 40
kDa species in the medium (~50% decrease at 100 µg/ml
ferric ammonium citrate). In addition, the amount of 50
kDa soluble RGMc increased. In agreement with these
results, incubation of cells with the iron chelator, deferox-
amine, prevented accumulation of 50 kDa RGMc in cul-
ture medium, and led to a ~30% rise in the amount of
soluble 40 kDa RGMc compared with cells incubated with
ferric ammonium citrate (Fig. 5B). Thus, iron delivery
appears to negatively regulate release of RGMc from the
membrane, and may also inhibit PC activity. In this
regard, Silvestri et al have found that deferoxamine
enhanced and iron loading decreased the abundance of
furin in HeLa cells [25].
Discussion
In this manuscript we show that RGMc accumulates in
extra-cellular fluid of cultured cells and in mouse and
human serum as 50 and 40 kDa protein species (Fig. 1).
As is evident from cell-surface binding experiments, both
molecules originate from cell-membrane-associated GPI-
linked single-chain RGMc (Fig. 3), and the 40 kDa iso-
form is derived from the 50 kDa species by targeted prote-
olysis mediated by PCs such as furin (Fig. 4), with
cleavage occurring at a site that is highly conserved among
RGMc orthologues, but is absent in the paralogues, RGMa
and RGMb (Fig. 1). Taken together, our results define a
key role for PCs in the regulation of RGMc that has impli-
cations for the physiological effects of this critical iron-
regulatory protein.
Are there specific biological effects of different RGMc 
protein species?
The biological actions of RGMc are not yet fully defined.
A role for RGMc in iron homeostasis is postulated based
on the discovery of multiple mutations in the HJV gene in
patients with JH [4-7], and on the iron overload pheno-
type in mice lacking hjv [8,9]. Loss of RGMc is associated
with severe reduction in hepcidin [4,8,9], a critical nega-
tive regulator of iron absorption, placing RGMc upstream
in a pathway controlling hepcidin production in the liver
[3]. Cell-associated RGMc can enhance effects of BMPs to
increase hepcidin gene expression, potentially through
direct binding to BMP2 and 4 [18,19], but it is not known
Altered processing of newly synthesized RGMc by PC inhibi- tion Figure 3
Altered processing of newly synthesized RGMc by PC 
inhibition. A. Time course of accumulation of RGMc on the 
cell surface and in conditioned medium after infection of 
Hep3B cells with Ad-HA-RGMc ± RVKR. Cell-surface pro-
teins were labeled with non-permeable biotin (EZ-link), fol-
lowed by incubation ± RVKR, and streptavidin pull-down, as 
described in 'Methods'. Immunoblot for cadherin measures 
sample loading. B. PC inhibition does not prevent acute 
release of RGMc from the cell surface. Membrane-associated 
RGMc was labeled with EZ-link, followed by incubation ± 
RVKR, and detection of soluble RGMc after streptavidin pull-
down by immunoblotting. For A – B, arrows are described 
in legend to Fig. 1. Similar results were observed with Cos-7 
cells.BMC Biochemistry 2008, 9:9 http://www.biomedcentral.com/1471-2091/9/9
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if these actions are mediated by single-chain or het-
erodimeric RGMc. In contrast, soluble RGMc appears to
inhibit production of hepcidin mRNA [15,20]. It is not
known if 50 or 40 kDa soluble RGMc proteins preferen-
tially bind to BMPs, or if they have other actions, although
a recent report showed that soluble 40 kDa RGMc blunted
stimulation of hepcidin gene expression by BMP2 in cul-
tured cells [20]. This latter observation indicates that PC
activity may influence the biological actions of RGMc.
Does iron regulate RGMc?
Serum levels of RGMc were shown to transiently increase
in acutely iron-deficent rats [24], and incubation of cul-
tured cells with holo-transferrin for 24 – 48 h caused a
reduction in RGMc in the medium [15,24]. This latter
effect was attributed to a decline in the extent of shedding
of membrane-linked RGMc [24]. We find in agreement
with these results that iron loading increased the amount
of single-chain RGMc on the cell membrane, and caused
a commensurate decline in accumulation of 40 kDa
RGMc in the extra-cellular fluid, while the abundance of
the soluble 50 kDa species increased. Additional work will
be needed to define the mechanisms by which iron alters
the biogenesis and processing of RGMc, although as sug-
gested by Silvestri et al [25], one possibility may be
through control of furin production.
Conclusion
RGMc, pro-protein convertases, and iron metabolism
The key observation in this manuscript is that a furin-like
PC cleaves 50 kDa full-length single-chain RGMc at a con-
served site to produce a 40 kDa soluble species. We find
that PC activity leads to the accumulation of 40 kDa
RGMc in medium of skeletal muscle cells, which endog-
enously synthesize RGMc [14], and in medium of several
cell types expressing recombinant RGMc. Moreover, we
show directly that purified recombinant furin can cleave
50 kDa RGMc in vitro. Recent reports from others also
implicate PCs in the cleavage of RGMc [25,26]. Using
Hek293 stably expressing human hemojuvelin/RGMc,
Lin et al have found that a PC inhibitor blocks that
appearance of a soluble form of the protein (sHJV), with
a larger species (ecto-HJV), probably equivalent to 50 kDa
mouse RGMc, accumulating instead [26]. Silvestri et al
have made similar observations in transfected HeLa cells
[25]. Our detection of both 50 and 40 kDa RGMc in
human and mouse serum further supports the physiolog-
ical significance of its PC-mediated proteolysis. A model
summarizing our results on processing of membrane-
associated RGMc is depicted in Fig. 6. As other studies
indicate that furin may be involved in processing and mat-
uration of several iron regulating proteins, including hep-
cidin, BMPs, and the soluble transferrin receptor [27-29],
these observations when taken together imply a diverse
and potentially important role for PCs in iron homeosta-
sis.
Furin cleaves soluble RGMc to produce the 40 kDa isoform Figure 4
Furin cleaves soluble RGMc to produce the 40 kDa isoform. A. Only 50 kDa RGMc accumulates in culture medium of 
cells expressing a protein with a modified PC cleavage site. Immunoblot of soluble RGMc from conditioned medium of Cos-7 
cells transfected with either wild-type (WT) RGMc or a derivative containing a mutated PC site (RXXRmut), after incubation ± 
RVKR. Similar results were observed with Hep3B cells. B. Hep3B cells cleave 50 kDa RGMc. RGMc was added to medium of 
Hep3B cells for 24 h ± RVKR, followed by immunoblotting (nt = non-treated). Identical results were seen with Cos-7 cells. C. 
Furin cleaves 50 kDa RGMc. Immunoblot shows results of in vitro incubation of soluble 50 kDa HA-RGMc ± recombinant furin. 
Antibodies are indicated. For A – C, arrows are as in legend to Fig. 1.BMC Biochemistry 2008, 9:9 http://www.biomedcentral.com/1471-2091/9/9
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A.Iron loading increases expression of RGMc on the cell membrane and diminishes accumulation in extra-cellular fluid Figure 5
A. Iron loading increases expression of RGMc on the cell membrane and diminishes accumulation in extra-cel-
lular fluid. A. Hep3B cells infected with Ad-HA-RGMc were incubated for 24 h with the concentrations of ferric ammonium 
citrate (FAC) indicated, followed by cell-surface biotin labeling, and detection of RGMc by immunoblotting in cell lysates (left 
panel), on the membrane after surface biotin labeling and streptavidin pull-down (middle panel), and in the medium (right 
panel). Similar results were observed with Cos-7 cells. B. Detection of RGMc by immunoblotting of conditioned medium from 
transiently transfected Cos-7 cells following incubation for 24 h with the concentrations of FAC or deferoxamine (DFO) indi-
cated. Identical results were seen with Hep3B cells. For A – B, arrows are as in legend to Fig. 2.BMC Biochemistry 2008, 9:9 http://www.biomedcentral.com/1471-2091/9/9
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